Ισραήλ - Αγγλικά - Ministry of Health

novartis israel ltd - amlodipine as besylate; valsartan - film coated tablets - amlodipine as besylate 10 mg; valsartan 160 mg - amlodipine - amlodipine - treatment of essential hypertension. exforge is indicated for patients whose blood pressure is not adequately controlled on monotherapy.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 80 mg; amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; crospovidone; hypromellose; purified talc; iron oxide yellow; macrogol 4000; titanium dioxide - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Ισραήλ - Αγγλικά - Ministry of Health

novartis israel ltd - amlodipine as besylate; valsartan - film coated tablets - amlodipine as besylate 5 mg; valsartan 80 mg - amlodipine - amlodipine - treatment of essential hypertension. exforge is indicated for patients whose blood pressure is not adequately controlled on monotherapy.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 320 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate; magnesium stearate; iron oxide yellow; crospovidone; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; macrogol 4000 - exforge is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Αρμενία - Αγγλικά - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

novartis pharma stein ag - amlodipine (amlodipine besilate), valsartan, hydrochlorothiazide - tablets film-coated - 5mg+ 160mg+ 12,5mg

Ουγκάντα - Αγγλικά - National Drug Authority

novartis pharma ag - amlodipine + valsartan - oral solid ordinary film-coated tablets - 10 mg + 160 mg

Αρμενία - Αγγλικά - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

novartis farma s.p.a - amlodipine (amlodipine besilate), valsartan - tablets film-coated - 10mg+ 160mg

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 160 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; crospovidone; hypromellose; purified talc; iron oxide red; macrogol 4000; iron oxide yellow; titanium dioxide - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); valsartan, quantity: 160 mg - tablet, film coated - excipient ingredients: magnesium stearate; crospovidone; microcrystalline cellulose; colloidal anhydrous silica; hypromellose; purified talc; iron oxide yellow; macrogol 4000; titanium dioxide - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Σαουδική Αραβία - Αγγλικά - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novartis, switzerland - valsartan,amlodipine besilate - film-coated tablet - 160,10 mg,